BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32157086)

  • 1. Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10.
    Buel GR; Chen X; Chari R; O'Neill MJ; Ebelle DL; Jenkins C; Sridharan V; Tarasov SG; Tarasova NI; Andresson T; Walters KJ
    Nat Commun; 2020 Mar; 11(1):1291. PubMed ID: 32157086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6AP AZUL interaction with UBQLN1/2 in cells, condensates, and an AlphaFold-NMR integrated structure.
    Buel GR; Chen X; Myint W; Kayode O; Folimonova V; Cruz A; Skorupka KA; Matsuo H; Walters KJ
    Structure; 2023 Apr; 31(4):395-410.e6. PubMed ID: 36827983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angelman syndrome-associated point mutations in the Zn
    Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
    J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity between Shuttle Factors and Substrates at the Proteasome.
    Chen X; Ebelle DL; Wright BJ; Sridharan V; Hooper E; Walters KJ
    J Mol Biol; 2019 Mar; 431(5):939-955. PubMed ID: 30664872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryo-EM Reveals Unanchored M1-Ubiquitin Chain Binding at hRpn11 of the 26S Proteasome.
    Chen X; Dorris Z; Shi D; Huang RK; Khant H; Fox T; de Val N; Williams D; Zhang P; Walters KJ
    Structure; 2020 Nov; 28(11):1206-1217.e4. PubMed ID: 32783951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
    Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
    Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.
    Ronchi VP; Klein JM; Edwards DJ; Haas AL
    J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
    Guharoy M; Bhowmick P; Tompa P
    J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of E6AP-independent degradation targets of HPV E6.
    Vats A; Thatte J; Banks L
    J Gen Virol; 2019 Dec; 100(12):1674-1679. PubMed ID: 31609195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
    Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
    J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex.
    Sailer C; Offensperger F; Julier A; Kammer KM; Walker-Gray R; Gold MG; Scheffner M; Stengel F
    Nat Commun; 2018 Oct; 9(1):4441. PubMed ID: 30361475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition.
    Uchiki T; Kim HT; Zhai B; Gygi SP; Johnston JA; O'Bryan JP; Goldberg AL
    J Biol Chem; 2009 May; 284(19):12622-32. PubMed ID: 19240029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence determinants of E2-E6AP binding affinity and specificity.
    Eletr ZM; Kuhlman B
    J Mol Biol; 2007 Jun; 369(2):419-28. PubMed ID: 17433363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
    Tomaić V; Banks L
    Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity.
    Beasley SA; Kellum CE; Orlomoski RJ; Idrizi F; Spratt DE
    PLoS One; 2020; 15(7):e0235925. PubMed ID: 32639967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E6AP inhibits G-CSFR turnover and functions by promoting its ubiquitin-dependent proteasome degradation.
    Chhabra S; Kumar Y; Thacker G; Kapoor I; Lochab S; Sanyal S; Bhatt MLB; Chattopadhyay N; Trivedi AK
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1545-1553. PubMed ID: 28578910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.
    Martínez-Noël G; Galligan JT; Sowa ME; Arndt V; Overton TM; Harper JW; Howley PM
    Mol Cell Biol; 2012 Aug; 32(15):3095-106. PubMed ID: 22645313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
    Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ronchi VP; Kim ED; Summa CM; Klein JM; Haas AL
    J Biol Chem; 2017 Nov; 292(44):18006-18023. PubMed ID: 28924046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.